Effect of Quinolone Prophylaxis Discontinuation During Pre-engraftment Neutropenia on Incidence, Mortality, and Etiology of Bloodstream Infections in Hematopoietic Stem-cell Transplant Recipients: A Systematic Review and Meta-analysis
Bruno Azevedo Randi, Hermes Ryoiti Higashino, Patrick Leon de Godoy Macedo, Thaís Guimarães, Bruno Garcia Pires, Vanderson Rocha, Alex Howard, Anna Sara Levin, Silvia Figueiredo Costa · 2026
Read Effect of Quinolone Prophylaxis Discontinuation During Pre-engraftment Neutropenia on Incidence, Mortality, and Etiology of Bloodstream Infections in Hematopoietic Stem-cell Transplant Recipients: A Systematic Review and Meta-analysis by Bruno Azevedo Randi, Hermes Ryoiti Higashino, Patrick Leon de Godoy Macedo, Thaís Guimarães, Bruno Garcia Pires, Vanderson Rocha, Alex Howard, Anna Sara Levin, Silvia Figueiredo Costa (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13280638.txt.
Description
Bruno Azevedo Randi and colleagues published a 2026 systematic review and meta-analysis of what happens when quinolone antibiotics are stopped in stem-cell transplant patients before the graft takes hold. Bloodstream infections are a danger in that window. Quinolones prevent many but breed resistant bacteria. Searching five databases, the team pooled ten studies covering 2,363 recipients, half kept on the drugs and half taken off them.
Continuing prophylaxis lowered infection risk by about a third and halved infections from Gram-negative bacteria. Among patients who did develop Gram-negative infections, however, prophylaxis was tied to higher odds that the organism resisted quinolones or carbapenems. Stopping the drugs did not raise infection-related death, and the resistance burden did not fall after stopping. The authors read the trade-off as genuine: fewer infections, nastier resistance when infections break through, and no mortality penalty for stopping. The findings support case-by-case decisions.
Catalog record
| CREATOR | Bruno Azevedo Randi, Hermes Ryoiti Higashino, Patrick Leon de Godoy Macedo, Thaís Guimarães, Bruno Garcia Pires, Vanderson Rocha, Alex Howard, Anna Sara Levin, Silvia Figueiredo Costa |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |